No Data
No Data
Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Path To Profitability
Oppenheimer's Top SMID Ideas Within High-growth Themes
Avadel Pharmaceuticals to Join Russell 3000 Index
Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29
Oppenheimer analyst Francois Brisebois maintains $Avadel Pharmaceuticals(AVDL.US)$ with a buy rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate o
Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27
Rodman & Renshaw analyst Brandon Folkes initiates coverage on $Avadel Pharmaceuticals(AVDL.US)$ with a buy rating, and sets the target price at $27.According to TipRanks data, the analyst has a succes
Express News | Vir Biotech rose by 19.66%, while novavax rose by 18.07%. Terns Pharmaceuticals, protagonist therapeutics, pacific biosciences of california, adaptive biotechnologies all rose by 16.84-13.27%. Avadel Pharmaceuticals Plc. dropped 3.82% and performed third
No Data